Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Change in Accured Expenses (2020 - 2025)

Pulse Biosciences has reported Change in Accured Expenses over the past 6 years, most recently at -$1.6 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$1.6 million for Q4 2025, down 150.76% from a year ago — trailing twelve months through Dec 2025 was -$3.4 million (down 207.41% YoY), and the annual figure for FY2025 was -$3.4 million, down 207.41%.
  • Change in Accured Expenses for Q4 2025 was -$1.6 million at Pulse Biosciences, down from $427000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for PLSE hit a ceiling of $3.2 million in Q4 2024 and a floor of -$3.0 million in Q1 2025.
  • Median Change in Accured Expenses over the past 5 years was $311500.0 (2022), compared with a mean of $82000.0.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 417.28% in 2023 and later skyrocketed 454.47% in 2024.
  • Pulse Biosciences' Change in Accured Expenses stood at $1.0 million in 2021, then plummeted by 59.72% to $408000.0 in 2022, then soared by 98.53% to $810000.0 in 2023, then soared by 295.68% to $3.2 million in 2024, then plummeted by 150.76% to -$1.6 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$1.6 million (Q4 2025), $427000.0 (Q3 2025), and $793000.0 (Q2 2025) per Business Quant data.